Skip to main content

BioVenture — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

279
Companies
$2.1B
Total invested
$23.9M
Avg. check
27
Industries
Biotechnology 14Health Care 9Medical 8Pharmaceutical 8Therapeutics 6Medical Device 5+21 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 279
Smartlens
October 2025

Clinical stage, novel technologies for managing Glaucoma

Health Care · Mountain View$5.2M Venture - Series Unknown
AeroRx Therapeutics
October 2025

AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.

Health Care · La Jolla$21.0M Series A
OncoC4
October 2025

OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.

Biopharma · Rockville$50.0M Series B
Nionyx Bio
September 2025

Nionyx Bio builds AAV-based gene therapies to address some of the most potent kidney genetic diseases.

Biotechnology · New York$4.0M Seed
ARTHEx Biotech
September 2025

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Biotechnology · Valencia$40.6M Series B
Navrogen
September 2025

Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.

Biotechnology · PhiladelphiaGrant
Rapafusyn Pharmaceuticals
September 2025

Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.

Biotechnology · Baltimore$16.0M Series A
Iterum Therapeutics
August 2025

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

Medical · Dublin$2.2M Post-IPO Equity
Cantai Therapeutics
July 2025

Cantai Therapeutics operates as a developer of drug candidates.

Life Science · Philadelphia$3.5M Seed
Cryosa
July 2025

CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.

Biotechnology · Minnesota City$6.0M Venture - Series Unknown
Infinity Bio
June 2025

Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.

Biometrics · Baltimore$8.0M Series A
Mosanna Therapeutics
June 2025

Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.

Biotechnology · Redwood City$80.0M Series A
UltraClear
May 2025

UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.

Beauty · Smithfield$23.0M Series B
Dermaliq Therapeutics
May 2025

Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.

Fitness · WilmingtonUndisclosed
Hillhurst Biopharmaceuticals
May 2025

Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.

Advanced Materials · San Diego$6.3M Grant
Hydrocision
April 2025

HydroCision develops, manufactures, and markets fluid jet-based surgical tools for minimally invasive spine surgery requirements.

Health Care · North Billerica$2.5M Venture - Series Unknown
Apeximmune Therapeutics
March 2025

Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.

Biotechnology · Burlingame$21.3M Series A
Myrobalan Therapeutics
March 2025

Myrobalan Therapeutics is a biotechnology company developing oral neurorestorative therapies for individuals with CNS diseases.

Biotechnology · Medford$850K Grant
Sonomotion
February 2025

Sonomotion is a medical device manufacturing company that specializes in providing medical solutions for kidney stones disease.

Clinical Trials · South San Francisco$2.2M Grant
Francis Medical
January 2025

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.

Medical · Maple Grove$80.0M Series C
Valora Therapeutics
November 2024

Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .

Biopharma · La Jolla$30.0M Seed
Artax Biopharma
August 2024

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

Biopharma · Cambridge$8.0M Convertible Note
Vico Therapeutics
June 2024

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

Health Care · Leiden$12.3M Series B
āshibio
June 2024

āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

Biotechnology · Brisbane$40.0M Series A

Where BioVenture invests

Biotechnology14
Health Care9
Medical8
Pharmaceutical8
Therapeutics6
Medical Device5

About BioVenture's portfolio

How many companies has BioVenture invested in?▸

BioVenture has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BioVenture invest in?▸

BioVenture's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 27 different industry categories.

What is BioVenture's largest investment?▸

Among tracked funding rounds, Mosanna Therapeutics received $80.0M in a Series A round. BioVenture's total known invested capital is $2.1B.

What is the average investment size for BioVenture?▸

BioVenture's average investment size is $23.9M across its portfolio of 279 companies.

What are BioVenture's most recent investments?▸

Recent BioVenture portfolio additions include Smartlens, AeroRx Therapeutics, OncoC4, Nionyx Bio, ARTHEx Biotech. These companies were founded in 2020 or later.

Reach the founders behind these 279 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →